LINC01194 and lung cancer: These data suggest that it is the Pep42 sequence in the CAR structure recognized by the tumor antigen csGRP78 that contributes CAR-T cells to kill these two lung cancer cell lines, rather than differentiated state distinctions of T cell subtypes due to CAR expression.